Skip to main content
SpringerLink
Log in

Oral antivirals are a key therapy for herpes zoster but do they reliably prevent postherpetic neuralgia?

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bansal R, Tutrone WD, Weinberg JM. Viral skin infections in the elderly: diagnosis and management. Drugs Aging 2002; 19(7): 503–14

    Article  PubMed  Google Scholar 

  2. Gnann Jr JW, Whitley RJ. Herpes zoster. N Engl J Med 2002 Aug 1; 347(5): 340–6

    Article  PubMed  Google Scholar 

  3. Nikkels AF, Piérard GE. Oral antivirals revisited in the treatment of herpes zoster: what do they accomplish? Am J Clin Dermatol 2002; 3(9): 591–8

    Article  PubMed  Google Scholar 

  4. Santee JA. Corticosteroids for herpes zoster: what do they accomplish? Am J Clin Dermatol 2002; 3(8): 517–24

    Article  PubMed  Google Scholar 

  5. Kost RG, Straus SE. Postherpetic neuralgia: pathogenesis, treatment, and prevention. N Engl J Med 1996; 335: 32–42

    Article  PubMed  CAS  Google Scholar 

  6. British National Formulary. No. 44. London: the Pharmaceutical Press, 2002 Sep

  7. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. NZ Med J 1989 Mar 8; 102(863): 93–5

    CAS  Google Scholar 

  8. Huff JC, Bean B, Balfour Jr HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med 1988 Aug 29; 85(2A): 84–9

    PubMed  CAS  Google Scholar 

  9. McKendrick MW, McGill JI, White JE, et al. Oral acyclovir in acute herpes zoster. Br Med J 1986 Dec 13; 293(6561): 1529–32

    Article  CAS  Google Scholar 

  10. Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized double-blind, placebo-controlled trial. Collaboratvie famciclovir herpes zoster study group. Ann Intern Med 1995 Jul 15; 123(2): 89–96

    PubMed  CAS  Google Scholar 

  11. Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995 Jul; 39(7): 1546–53

    Article  PubMed  CAS  Google Scholar 

  12. Tyring SK, Beutner KR, Tucker BA, et al. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000; 9(9): 863–9

    Article  PubMed  CAS  Google Scholar 

  13. Wood MJ, Johnson RW, McKendrick MW, et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330: 896–900

    Article  PubMed  CAS  Google Scholar 

  14. Whitley RJ, Weiss H, Gnann W, et al. Acyclovir with and without prednisone for the treatment of herpes zoster. Ann Intern Med 1996; 125: 376–83

    PubMed  CAS  Google Scholar 

  15. Dworkin RH, Perkins FM, Nagasako EM. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin J Pain 2000 Jun; 16(2 Suppl.): S90–100

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oral antivirals are a key therapy for herpes zoster but do they reliably prevent postherpetic neuralgia?. Drugs Ther. Perspect 19, 14–18 (2003). https://doi.org/10.2165/00042310-200319100-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200319100-00005

Keywords

Search

Navigation